| pubmed-article:12138819 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12138819 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12138819 | lifeskim:mentions | umls-concept:C1556084 | lld:lifeskim |
| pubmed-article:12138819 | lifeskim:mentions | umls-concept:C0017319 | lld:lifeskim |
| pubmed-article:12138819 | lifeskim:mentions | umls-concept:C0034394 | lld:lifeskim |
| pubmed-article:12138819 | lifeskim:mentions | umls-concept:C1456822 | lld:lifeskim |
| pubmed-article:12138819 | lifeskim:mentions | umls-concept:C0040711 | lld:lifeskim |
| pubmed-article:12138819 | lifeskim:mentions | umls-concept:C1519941 | lld:lifeskim |
| pubmed-article:12138819 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:12138819 | pubmed:dateCreated | 2002-7-25 | lld:pubmed |
| pubmed-article:12138819 | pubmed:abstractText | Intermittent claudication is one of the clinical symptoms of peripheral arterial disease (PAD). The presence of PAD is a high risk marker of cardiac events and stroke. The PAD screening can be enhanced by the use of questionnaires. The Edinburgh Questionnaire presents in its English version better diagnostic performances compared to the Rose (WHO) Questionnaire. The aim of this study is to precise the performances of the French version of the Edinburgh Questionnaire among a population consulting general practitioners. | lld:pubmed |
| pubmed-article:12138819 | pubmed:language | fre | lld:pubmed |
| pubmed-article:12138819 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12138819 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12138819 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12138819 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:12138819 | pubmed:issn | 0003-9683 | lld:pubmed |
| pubmed-article:12138819 | pubmed:author | pubmed-author:LacroixPP | lld:pubmed |
| pubmed-article:12138819 | pubmed:author | pubmed-author:AboyansVV | lld:pubmed |
| pubmed-article:12138819 | pubmed:author | pubmed-author:LégerPP | lld:pubmed |
| pubmed-article:12138819 | pubmed:author | pubmed-author:BoissierCC | lld:pubmed |
| pubmed-article:12138819 | pubmed:author | pubmed-author:BressolletteL... | lld:pubmed |
| pubmed-article:12138819 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12138819 | pubmed:volume | 95 | lld:pubmed |
| pubmed-article:12138819 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12138819 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12138819 | pubmed:pagination | 596-600 | lld:pubmed |
| pubmed-article:12138819 | pubmed:dateRevised | 2009-2-13 | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:meshHeading | pubmed-meshheading:12138819... | lld:pubmed |
| pubmed-article:12138819 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:12138819 | pubmed:articleTitle | [Validation of a French translation of the Edinburgh claudication questionnaire among general practitioners' patients]. | lld:pubmed |
| pubmed-article:12138819 | pubmed:affiliation | Unité de médecine vasculaire, service de CTCV et angiologie, CHU Dupuytren, 2 avenue M.-L. King, 87042 Limoges. lacroix@unilim.fr | lld:pubmed |
| pubmed-article:12138819 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12138819 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:12138819 | pubmed:publicationType | Validation Studies | lld:pubmed |
